C. Guarnaccia

583 total citations
7 papers, 242 citations indexed

About

C. Guarnaccia is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, C. Guarnaccia has authored 7 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in C. Guarnaccia's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Viral-associated cancers and disorders (3 papers). C. Guarnaccia is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Viral-associated cancers and disorders (3 papers). C. Guarnaccia collaborates with scholars based in Italy, Australia and Brazil. C. Guarnaccia's co-authors include Matthew R. Sydes, Jan Walewski, Michael Lewis, Andrew Grigg, Graham M. Mead, Chris S.R Hatton, J. McKendrick, Sally Stenning, Daniel Wright and Giuseppe Rossi and has published in prestigious journals such as Annals of Oncology, Leukemia Research and Leukemia & lymphoma.

In The Last Decade

C. Guarnaccia

7 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Guarnaccia Italy	5	200	150	96	88	26	7	242
Cristina Becchimanzi Italy	8	168 0.8×	111 0.7×	71 0.7×	72 0.8×	30 1.2×	19	232
Marianna Sassone Italy	6	150 0.8×	66 0.4×	107 1.1×	50 0.6×	22 0.8×	16	183
Neel K. Gupta United States	6	173 0.9×	90 0.6×	152 1.6×	97 1.1×	15 0.6×	17	247
Paolo Avanzini Italy	8	129 0.6×	76 0.5×	51 0.5×	39 0.4×	9 0.3×	24	173
Christina Howlett United States	6	144 0.7×	97 0.6×	44 0.5×	70 0.8×	22 0.8×	11	171
Lourdes Martín‐Martín Spain	6	86 0.4×	106 0.7×	58 0.6×	45 0.5×	18 0.7×	6	238
Sergio Fava Italy	5	77 0.4×	75 0.5×	37 0.4×	46 0.5×	14 0.5×	10	165
Concepción Nicolás Spain	6	102 0.5×	42 0.3×	112 1.2×	93 1.1×	39 1.5×	10	191
Frank Kauff Germany	6	244 1.2×	179 1.2×	32 0.3×	161 1.8×	6 0.2×	8	273
P Cony-Makhoul France	6	104 0.5×	98 0.7×	60 0.6×	59 0.7×	72 2.8×	9	254

Countries citing papers authored by C. Guarnaccia

Since Specialization

Citations

This map shows the geographic impact of C. Guarnaccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Guarnaccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Guarnaccia more than expected).

Fields of papers citing papers by C. Guarnaccia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Guarnaccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Guarnaccia. The network helps show where C. Guarnaccia may publish in the future.

Co-authorship network of co-authors of C. Guarnaccia

This figure shows the co-authorship network connecting the top 25 collaborators of C. Guarnaccia. A scholar is included among the top collaborators of C. Guarnaccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Guarnaccia. C. Guarnaccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Mead, Graham M., Matthew R. Sydes, Jan Walewski, et al.. (2002). An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study. Annals of Oncology. 13(8). 1264–1274. 212 indexed citations

2.

Mead, G.M., Matthew R. Sydes, Jan Walewski, et al.. (2002). An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study Ann Oncol 2002; 13: 1264–1274. Annals of Oncology. 13(12). 1961–1961. 6 indexed citations

3.

Federico, Massimo, Teodoro Chisesi, L Resegotti, et al.. (1994). Long Term Results of Interferon Treatment in Hairy Cell Leukemia Italian Cooperative Group of Hairy Cell Leukemia (ICGHCL). Leukemia & lymphoma. 14(5-6). 457–464. 8 indexed citations

4.

Federico, Massimo, Teodoro Chisesi, L Resegotti, et al.. (1991). Should alpha interferon be used as primary treatment for hairy cell leukemia?. Leukemia Research. 15(6). 419–426. 9 indexed citations

5.

Majolino, Ignazio, Rosanna Scimè, A Indovina, et al.. (1991). Treatment of malignant lymphomas with very-high-dose CVB followed by transplantation of autologous blood stem cells collected after mobilizing chemotherapy.. PubMed. 76 Suppl 1. 66–71. 4 indexed citations

6.

Federico, Massimo, Antonio Frassoldati, G. Pagnucco, et al.. (1989). Human lymphoblastoid α-interferon for hairy cell leukemia. An update of the Italian Cooperative Group. 4. 179–181. 2 indexed citations

7.

Federico, Massimo, Antonio Frassoldati, G. Pagnucco, et al.. (1989). Human lymphoblastoid alpha-interferon for hairy cell leukemia. An update of the Italian Cooperative Group.. PubMed. 4 Suppl 1. 179–81. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact